The clinical utility of the GOLD classification of COPD disease severity in pulmonary rehabilitation

Respiratory Medicine

Volumn 102, Issue 1, 2008, Pages 162-171

  Huijsmans, Rosalie J ^a,b   de Haan, Arnold ^a   ten Hacken, Nick N H T ^c   Straver, Renata V M ^a   van't Hul, Alex J ^a,d  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d Rehabilitation Centre Breda   (Netherlands)

Author keywords

BODE index; COPD; Discriminatory capacity; Global Initiative for Chronic Obstructive Lung Disease (GOLD); Health status; Pulmonary rehabilitation

Indexed keywords

SALBUTAMOL;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DYSPNEA; EXERCISE; FEMALE; HEALTH STATUS; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PULMONARY REHABILITATION; QUALITY OF LIFE; QUESTIONNAIRE; TREATMENT OUTCOME;

AGED; ANALYSIS OF VARIANCE; BODY MASS INDEX; DYSPNEA; EXERCISE TOLERANCE; FEMALE; HUMANS; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

EID: 36349034581     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.07.008     Document Type: Article

References (33)

1. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. Am J Respir Crit Care Med 152 5 Pt 2 (1995) S77-S121
2. BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD guidelines Group of the Standards of Care Committee of the BTS. Thorax 52 Suppl 5 (1997) S1-S28
3. Celli B.R. Current thoughts regarding treatment of chronic obstructive pulmonary disease. Med Clin North Am 80 (1996) 589-609
4. Agustí A.G. COPD, a multicomponent disease: implications for management. Respir Med 99 (2005) 670-682
5. Pauwels R.A., Buist A.S., Calverly P.M., Jenkins C.R., and Hurd S.S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 163 (2001) 1256-1276
6. Calverley P.M. The GOLD classification has advanced understanding of COPD. Am J Respir Crit Care Med 170 (2004) 211-212
7. Mannino D.M., Doherty D.E., and Sonia Buist A. Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. Respir Med 100 (2006) 115-122
8. Ekberg-Aronsson M., Pehrsson K., Nilssson J.A., Nilsson P.M., and Lofdahl C.G. Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis. Respir Res 6 (2005) 98
9. Schols A.M., Broekhuizen R., Weling-Scheepers C.A., and Wouters E.F. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 82 (2005) 53-59
10. Kerstjens H.A. The GOLD classification has not advanced understanding of COPD. Am J Respir Crit Care Med 170 (2004) 212-213
11. The Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2006. Available from: 〈http://www.goldcopd.org〉. Date last accessed: July 10, 2007.
12. Celli B.R., Cote C.G., Marin J.M., et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350 (2004) 1005-1012
13. Halpin D. NICE guidance for COPD. Thorax 2004; 59:181-2.
14. Standardized lung function testing. Official statement of the European Respiratory Society. Eur Respir J Suppl 16 (1993) 1-100
15. Quanjer P.H., Tammeling G.J., Cotes J.E., Pedersen O.F., Peslin R., and Yernault J.C. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 16 (1993) 5-40
16. Cotes J.E., Chinn D.J., Quanjer P.H., Roca J., and Yernault J.C. Standardization of the measurement of transfer factor (diffusion capacity). Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 16 (1993) 41-52
17. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS Statement: guidelines for the six-minute walk test. Am J Resp Crit Care Med 166 (2002) 111-117
18. Troosters T., Gosselink R., and Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J 14 (1999) 270-274
19. Clinical exercise testing with reference to lung diseases: indications. Standardization and interpretation strategies. ERS Task Force on Standardization of Clinical Exercise Testing. European Respiratory Society. Eur Respir J 10 (1997) 2662-2689
20. Jones N.L., Summers E., and Killian K.J. Influence of age and stature on exercise capacity during incremental cycle ergometry in men and women. Am Rev Respir Dis 140 (1989) 1373-1380
21. Jones N.L. Normal values for pulmonary gas exchange during exercise. Am Rev Respir Dis 129 (1984) S44-S46
22. Bestall J.C., Paul E.A., Garrod R., Garnham R., Jones P.W., and Wedzicha J.A. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 54 (1999) 581-586
23. Jones P.W., Quirk F.H., Baveystock C.M., and Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George Respiratory Questionnaire. Am Rev Respir Dis 145 (1992) 1321-1327
24. Jones P.W. Interpreting thresholds for a clinically significant change in health status in asthma and COPD. Eur Resp J 19 (2002) 398-404
25. Nordenfelt I., and Svensson G. The transfer factor (diffusing capacity) as a predictor of hypoxaemia during exercise in restrictive and chronic obstructive pulmonary disease. Clin Physiol 7 (1987) 423-430
26. Pinto-Plata V.M., Cote C., Cabral H., Taylor J., and Celli B.R. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J 23 (2004) 28-33
27. Bowen J.B., Votto J.J., Thrall R.S., et al. Functional status and survival following pulmonary rehabiliation. Chest 118 (2000) 697-703
28. Takigawa N., Tada A., Soda R., et al. Comprehensive pulmonary rehabilitation according to severity of COPD. Respir Med 101 (2007) 336-432
29. Ketelaars C.A., Schlosser M.A., Mostert R., Huyer Abu-Saad H., Halfens R.J., and Wouters E.F. Determinants of health related quality of life in patients with chronic obstructive pulmonary disease. Thorax 51 (1996) 39-43
30. Antonelli-Incalzi R., Imperiale C., Bellia V., et al. Do GOLD stages of COPD disease severity really correspond to differences in health status?. Eur Respir J 22 (2003) 444-449
31. Ferrer M., Alonso J., Morera J., et al. Chronic obstructive pulmonary disease stage and health related quality of life. The quality of life of chronic obstructive pulmonary disease study group. Ann Intern Med 127 (1997) 1072-1079
32. Köhler D., Fisher J., Raschke F., and Schönhofer B. Usefulness of GOLD classification of COPD severity. Thorax 58 (2003) 825
33. Wijnhoven H.A., Kriegsman D.M., Hesselink A.E., de Haan M., and Schellevis F.G. The influence of co-morbidity on health related quality of life in asthma and COPD patients. Respir Med 97 (2003) 468-475